FIELD: medicine.
SUBSTANCE: invention concerns treating hypertension. Composition for treating hypertension (version 3, including treatment of hypertension in black patients) containing nebivolol or its salt, and from 1 to 1,200 mg Angiotensin II receptor antagonist, selected from group consisting of olmesartana, losartan, valsartan and their pharmaceutically acceptable salts.
EFFECT: what is shown is synergism of blood pressure reduction by declared combination.
12 cl, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS CONTAINING NEBIVOLOL | 2005 |
|
RU2441653C2 |
| GLUCURONIDATED NEBIVOLOL METABOLITES | 2006 |
|
RU2413518C2 |
| PHARMACEUTIC COMPOSITION, WHICH CONTAINS HYDROXYLATED NEBIVOLOL | 2006 |
|
RU2433823C2 |
| PHARMACEUTICAL COMPOSITION ELICITING IMPROVED ANTITUMOR EFFECT AND/OR REDUCED ADVERSE EFFECTS AND COMPRISING ANTITUMOR AGENT AND DERIVATIVE OF HYDROXAMIC ACID | 1998 |
|
RU2254129C2 |
| CONDENSED HETEROCYCLIC SUCCINAMIDE COMPOUNDS | 2001 |
|
RU2298554C2 |
| METHOD OF PRODUCING DERIVATIVES OF DELTA 4-9-19-NORSTEROIDS | 0 |
|
SU1340593A3 |
| 19,11-BRIDGED OVER 4-ESTRENES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, INTERMEDIATE COMPOUNDS | 1993 |
|
RU2157814C2 |
| METHOD FOR THE SYNTHESIS OF STEROID, SUBSTITUTED WITH SPIRANE CYCLE | 0 |
|
SU1715205A3 |
| TLR7 AGONISTS | 2019 |
|
RU2817014C2 |
| AGONISTS OF 5-HT4-RECEPTORS FOR TREATING DEMENTIA | 2011 |
|
RU2569733C2 |
